Summary

Biogen, Inc. - Company Profile and SWOT Analysis

Summary

Biogen, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Biogen, Inc. (Biogen or 'the company') discovers, develops, manufactures and commercializes therapies in the areas of hematology, neurology and immunology. The company develops therapies for multiple sclerosis, neuroimmunology movement disorders, including Parkinson's disease, Alzheimer's disease and dementia, and neuromuscular disorders, including amyotrophic lateral sclerosis and spinal muscular atrophy. It also develops and manufactures biosimilars of advanced biologics. The company markets its products under Flixabi, Benepali, Imraldi, Spinraza, Tecfidera, Avonex, Tysabri, Eylea, Gazyva, Fampyra, Plegridy and Fumaderm brand names. Biogen has business operations in the North America, Asia and Europe. The company is headquartered in Weston, Massachusetts, the US.

Scope

- Detailed information on Biogen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Biogen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Biogen, Inc. including a breakdown and examination of key business segments
- Intelligence on Biogen, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Biogen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Biogen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Biogen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Biogen, Inc.'s business structure, strategy and prospects.

ページTOPに戻る

Table of Contents

Table of Contents
Company Snapshot
Biogen, Inc.: Company Overview
Biogen, Inc.: Overview and Key Facts
Biogen, Inc.: Overview
Biogen, Inc.: Key Facts
Biogen, Inc.: Key Employees
Biogen, Inc.: Key Employee Biographies
Biogen, Inc.: Major Products and Services
Biogen, Inc.: Management Statement
Biogen, Inc.: Key Competitors
Biogen, Inc.: Company Analysis
Biogen, Inc.: Business Description
Biogen, Inc.: SWOT Analysis
Biogen, Inc.: SWOT Overview
Biogen, Inc.: Strengths
Biogen, Inc.: Weaknesses
Biogen, Inc.: Opportunities
Biogen, Inc.: Threats
Biogen, Inc.: Corporate Financial Deals Activity
Biogen, Inc.: Financial Deals Overview
Biogen, Inc.: Targets and Partners
Biogen, Inc.: Top Deals 2021 - 2025YTD*
Biogen, Inc.: Advisors
Biogen, Inc.: Top Legal Advisors
Biogen, Inc.: Top Financial Advisors
Biogen, Inc.: Mergers and Acquisitions
Biogen, Inc.: Corporate Venturing
Biogen, Inc.: Capital Raising
Biogen, Inc.: Partnership
Biogen, Inc.: Divestments
Biogen, Inc.: Recent Developments
Biogen, Inc.: News and Events Summary
Biogen, Inc.: Corporate Governance
Biogen, Inc.: Financial Performance
Biogen, Inc.: Market Developments
Biogen, Inc.: Regulatory and Legal Events
Biogen, Inc.: Research & Development
Biogen, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1: Biogen, Inc.: Key Facts
Table 2: Biogen, Inc.: Key Employees
Table 3: Biogen, Inc.: Key Competitors
Table 4: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Biogen, Inc.: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Table 6: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Table 7: Biogen, Inc.: Targets and Partners
Table 8: Biogen, Inc.: Top Deals 2021 - 2025YTD*
Table 9: Biogen, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Biogen, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Biogen, Inc.: M&A Volume and Value Trend (2021 - YTD*2025)
Table 12: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2021 - YTD*2025)
Table 13: Biogen, Inc.: Capital Raising Volume and Value Trend (2021 - YTD*2025)
Table 14: Biogen, Inc.: Capital Raising by Deal Type (2021 - YTD*2025)
Table 15: Biogen, Inc.: Partnership Volume and Value Trend (2021 - YTD*2025)
Table 16: Biogen, Inc.: Partnership Trend by Deal Type (2021 - YTD*2025)
Table 17: Biogen, Inc.: Divestments Volume and Value Trend (2021 - YTD*2025)
Table 18: Biogen, Inc.: Divestments by Geography (2021 - YTD*2025)
Table 19: Biogen, Inc.: News and Events Summary
Table 20: Biogen, Inc.: Corporate Governance
Table 21: Biogen, Inc.: Financial Performance
Table 22: Biogen, Inc.: Market Developments
Table 23: Biogen, Inc.: Regulatory and Legal Events
Table 24: Biogen, Inc.: Research & Development
Table 25: Biogen, Inc.: Strategy and Operations